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ABSTRACT
N-methyl-D-aspartate-type glutamate receptors (NMDARs) are
ligand-gated ion channels activated by coagonists glutamate
and glycine. NMDARs play a critical role in synaptic plasticity
and excitotoxicity, largely because of their high calcium per-
meability and slow deactivation and desensitization kinetics.
NR1 is an obligate subunit in all NMDAR complexes, where it
combines with NR2A, 2B, 2C, and/or 2D. NR1 binds glycine,
and residue Asn598 in the re-entrant membrane loop M2
largely determines NMDAR calcium permeability. In contrast,
NR2 subunits bind glutamate and contain regions that regulate
receptor desensitization and deactivation. Here, we report that
mutations of NR1(Asn598) in combination with wild-type NR2A,
expressed in human embryonic kidney 293 cells, exhibit altered
glycine-independent desensitization. In the absence of extra-
cellular calcium, substitution of Arg for Asn598 (NR1R) slowed
desensitization by 2- to 3-fold compared with wild-type NR1/
NR2A, and glutamate-evoked peak current EC50 and deactiva-
tion rate were also affected. Replacement of Asn by Gln (NR1Q)
produced two distinct rates of calcium- and glycine-indepen-
dent desensitization. Moreover, in the presence of extracellular
calcium, the voltage-dependent pore block by calcium for the
NR1Q mutant mimicked the effects of the positively charged
Arg at this site in NR1R on slowing desensitization and deac-
tivation. A kinetic model of the NMDA receptor-channel sug-
gests that these results can be explained by altered gating and
not ligand binding. Our data increase understanding of the role
that amino acids within the NMDAR pore play in channel gating.
The highly Ca2 permeable N-methyl-D-aspartate (NMDA)
subclass of ionotropic glutamate receptors plays a critical
role in synaptic plasticity as well as neuronal death in stroke
and neurodegenerative disorders (Dingledine et al., 1999).
Previous studies have shown that glutamate receptor desen-
sitization is protective against excitotoxicity (Raymond et al.,
1996 and references therein). Although NMDA receptors
(NMDARs) desensitize more slowly and less extensively than
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type
glutamate receptors, NMDAR activity is limited during sus-
tained glutamate stimulation by a variety of processes, in-
cluding Ca2- and glycine-independent desensitization (re-
viewed by McBain and Mayer, 1994). N-terminal regions of
the NR2 subunit that flank the S1 segment of the agonist-
binding domain (Stern-Bach et al., 1994) are involved in this
form of desensitization, including the leucine/isoleucine/va-
line-binding protein-like domain and four amino acids imme-
diately preceding the first membrane domain (M1) (Krupp et
al., 1998; Villarroel et al., 1998). In addition, Ca2- and
glycine-independent desensitization, as well as deactivation,
of NMDAR-mediated current is modified by a point mutation
of NR1 in the highly conserved motif (SYTANLAAF) (Kohda
et al., 2000) that connects M3 with S2, which is also involved
in agonist binding (Stern-Bach et al., 1994). In both cases,
regions identified as modifying desensitization gating con-
nect agonist-binding regions to membrane domains involved
in pore formation, and these connector regions have been
proposed to couple ligand binding and channel gating (Krupp
et al., 1998; Villarroel et al., 1998; Jones et al., 2002).
On the other hand, residues within the NMDAR M2 seg-
ment of the pore region are generally viewed as sites for
control of ion permeability. The Asn/Gln/Arg site, at the apex
of the re-entrant M2 loop, contributes to forming the narrow-
est region of the glutamate receptor pore and is critical to
controlling block and permeability of divalent ions (Burna-
shev et al., 1992, 1996; Mori et al., 1992; Sakurada et al.,
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1993; Wollmuth et al., 1996) as well as single channel con-
ductance (Behe et al., 1995). NMDARs have asparagine at
this site and relatively high Ca2 permeability, whereas non-
NMDA-type glutamate receptors have either glutamine or
arginine and lower or negligible Ca2 permeability, respec-
tively. Asn598 in NR1 makes the largest contribution to
determining the high Ca2 permeability of NMDARs. Inter-
estingly, one study using single-channel recording showed
that substitution of Gln at this site [NR1(N598Q)], combined
with NR2A, could alter channel gating under bi-ionic condi-
tions because of differential binding of monovalent ions in the
permeation pathway (Schneggenburger and Ascher, 1997).
Moreover, recent evidence from studies using the scanning
cysteine accessibility method and trapping blockers suggests
that Asn598, along with two amino acids in M3—Val626 and
Thr630—in NR1 lie very near the channel activation gate,
which is postulated to be formed by the M2 loop (Sobolevsky
et al., 2002).
To further investigate a role for the Asn/Gln/Arg site deep
within the pore in modulating NMDAR channel gating, we
re-examined properties of receptors composed of NR2A to-
gether with NR1A containing Asn (wild-type), Gln, or Arg at
position 598. Recombinant receptors were expressed in
HEK293 cells to allow analysis of mutant receptors and fa-
cilitate ultra-fast solution exchange during whole-cell patch
clamp recording. We report experimental and modeling evi-
dence to support that the Asn/Gln/Arg site plays a critical
role in channel closing and desensitization of the NMDAR.
Materials and Methods
Cell Culture and Transfection. Culture and transfection of
HEK293 cells (American Type Culture Collection, Manassas, VA)
were performed as described previously (Chen et al., 1997). Briefly,
cells were passaged every 2 to 4 days. For Ca2 phosphate transfec-
tion, cells were plated at a density of 1 106 cells/ml in 10-cm culture
dishes (Falcon; Becton Dickinson Labware, Franklin Lakes, NJ).
Cells were transfected with cDNAs encoding NR2A and either wild-
type (WT) NR1A, NR1A(N598R), or NR1A(N598Q) at a ratio of 1:1.
A total of 10 g of plasmid cDNA was used for transfection of a 10-cm
culture plate. After transfection, 1 mM ()-2-amino-5-phosphono-
pentanoic acid (RBI/Sigma, Natick, MA) was added to the culture
media and the cells were transferred onto glass coverslips in 35-mm
culture plates (Falcon).
Electrophysiology. The whole-cell, patch-clamp recording tech-
nique and recording solutions for HEK293 cells were essentially the
same as described previously (Chen et al., 1997). Twenty-four to 36 h
after the start of transfection, the HEK293 cells were transferred to
the recording chamber on the stage of an inverted microscope (Av-
iovert 100; Carl Zeiss, Thornburg, NY). Agonist-evoked currents
were recorded in the whole-cell mode under voltage clamp (VH60
mV) at room temperature (22°C). Electrodes with open tip resis-
tances of 1 to 5 M were used. After establishing the whole-cell
mode, cells were lifted from the coverslip. Ultrafast application of
agonists was achieved by a piezo-driven -shaped tube (Hilgenburg,
Malsfeld, Germany) (Chen et al., 1997). Control and agonist solu-
tions were continuously gravity-fed through the two sides of the
-shaped tube. Solution exchange time (10-to-90% rise time) across
the open tip of the recording electrode was 0.2 ms. The extracellular
recording solution contained 145 mM NaCl, 5.4 mM KCl, 1.8 mM
CaCl2, 11 mM glucose, and 10 mM HEPES, titrated to pH 7.35 with
NaOH. EGTA or N,N,N,N-tetrakis-[2-pyridylmethyl]-ethylenedia-
mine (TPEN) was added to the external solution in some experi-
ments to avoid contamination by zinc, as indicated. In all experi-
ments, the external solution contained no added Mg2 to enhance
NMDAR-mediated currents at negative holding potentials, and 50
M glycine was added to both control and glutamate-containing
solutions. The intracellular recording solution contained 145 mM
KCl, 10 mM HEPES, 5.5 mM BAPTA, 4 mM MgATP, 0.5 mM CaCl2,
2 mM MgCl2, and 2 mM tetraethylammonium, titrated to pH 7.2
with NaOH. Currents were sampled at 2 kHz and acquired and
analyzed using pCLAMP software and the Axopatch 200A amplifier
(Axon Instruments, Foster City, CA). Results are expressed as the
mean  S.E.M. For calculation of EC50 values for both experiments
and simulations, the amplitude of the glutamate-evoked current was
measured at the peak of the response. Peak response EC50 was
calculated from the equation: I  Imax  [1 / (1  (EC50/[A])
nH)],
where I is the measured peak current amplitude, Imax is the maxi-
mum peak current amplitude (evoked by 1 mM glutamate), [A] is the
agonist concentration, and nH is the Hill coefficient.
Site-Directed Mutagenesis. Mutant NR1A cDNAs were gener-
ated by site-directed mutagenesis of wild-type NR1A cDNA as de-
scribed previously (Raymond et al., 1996). The antisense primers
5-CCCAATGCCGGACTGGAGCAGGACGCCC-3 and 5-CCCAAT-
GCCGGACCGGAGCAGGACGCCC-3 were used to generate
NR1(N598Q) and NR1(N598R), respectively (single letter amino acid
code, mature protein).
Simulation and Modeling. For simulation of NMDAR activa-
tion, we began by modifying previous kinetic models (Clements and
Westbrook, 1991; Hessler et al., 1993; Destexhe et al., 1998; see also
Chen et al., 2001). Because there was no Mg2 in our extracellular
recording solutions, Mg2 block of NMDARs was not taken into
consideration in the modeling. The NMDAR current was described
by the product of maximal conductance (gNMDA), the driving force,
and open probability Po: INMDA  gNMDA  Po  (V  ENMDA). The
maximal conductance gNMDA was set to 0.05 nS in all simulations,
and the reversal potential ENMDA was 0 mV (Destexhe et al., 1998).
The model assumed two (independent) glutamate binding sites that
must both be occupied for the channel to open [giving three different
closed states (C0, C1, and C2), one desensitized form of the receptor
(D1), and an open state (O)], as we proposed previously (Chen et al.,
2001) (Fig. 4A). In this model, Rb is the binding rate of glutamate to
the NMDAR, Ru is the unbinding rate of glutamate, Ro is the opening
rate of the double-liganded receptor, Rc is the closing rate, Rd is the
desensitization rate, Rr is the resensitization rate, and [A] indicates
agonist concentration. Rd and Rr were set based on experimentally
measured values; Ru, Rb, and Ro were assigned values based on work
published previously (Chen et al., 2001); and Rc was adjusted until
the resulting model current response matched the peak glutamate
EC50, 10-to-90% rise time, Iss/Ip, and deactivation time constant
measured for the NMDAR mutant with a 3-s application of gluta-
mate. We performed our simulation using NEURON (version 4.1.1)
(Hines and Carnevale, 1997) on a PII-450 PC, using a 5- to 100-s
time step (depending on the kinetic model used).
Results
NMDARs composed of NR2 subunits combined with mu-
tant NR1A containing Gln or Arg instead of Asn at position
598 in the pore exhibit decreased or negligible Ca2 perme-
ability, respectively (Burnashev et al., 1992; Sakurada et al.,
1993). These mutant receptors have been used in previous
studies to discern the role of NMDAR-mediated Ca2 influx
in a variety of cellular processes as well as to investigate the
stoichiometry of the NMDAR complex (Behe et al., 1995). In
this study, we re-examined the properties of NMDARs com-
posed of NR2A and NR1A compared with NR2A and mutant
NR1A(N598Q) or NR1A(N598R) (referred to as NR1Q or
NR1R, respectively) to determine whether mutations at this
site in the pore could affect other receptor channel properties,
such as gating.
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Wild-type NR1/NR2A (WT)-mediated currents evoked by a
3-s application of 1 mM glutamate (in the presence of satu-
rating glycine of 50 M) showed significant desensitization
when recorded in 1.8 mM extracellular Ca2 (Fig. 1A). Ca2-
dependent inactivation (reviewed by McBain and Mayer,
1994) and the acceleration of agonist-induced desensitization
by ambient zinc (Chen et al., 1997; Zheng et al., 2001) both
may contribute to the rapid rate and large extent of current
decay during sustained application of this saturating agonist
concentration. When the same cell was superfused with ex-
ternal solution containing no added Ca2 and 1 M TPEN or
5 mM EGTA to chelate residual Ca2 and zinc, desensitiza-
tion was characterized by a single exponential decay with a
time constant of 1.6 s and high steady state-to-peak current
ratio (Iss/Ip) at the end of the agonist application (Fig. 1A;
Table 1), similar to previously published data (Zheng et al.,
2001). This process represents agonist-induced Ca2-, Zn2-,
and glycine-independent desensitization (Krupp et al., 1998;
Zheng et al., 2001).
N598R Mutation Slows Agonist-Induced Desensitiza-
tion, Deactivation, and Shifts the Glutamate EC50. In
contrast to wild-type receptors, currents recorded from cells
expressing the Ca2-impermeable NR1R showed no Ca2-
dependent inactivation (Fig. 1A). Strikingly, these currents
also showed minimal agonist-induced desensitization during
the 3-s application of 1 mM glutamate in the presence of a
zinc chelator and a saturating glycine concentration (Fig. 1A;
Table 1). Furthermore, recovery from desensitization for this
mutant receptor was also dramatically slowed (Fig. 1, B and
C; Table 1; P 	 0.0001 by two-way analysis of variance). On
the other hand, currents recorded in the absence of a zinc
chelator exhibited substantial desensitization (Iss/Ip of 0.68
0.06, D of 1.4  0.3 s, n  4; data not shown); this increase
in rate and extent of desensitization was qualitatively simi-
lar to effects seen for wild-type NR1A/NR2A (Chen et al.,
1997; Zheng et al., 2001) caused by contamination of the
external solution by nanomolar zinc. This effect could be
explained by the allosteric interaction between the zinc and
glutamate binding sites (Zheng et al., 2001), independent of
desensitization gating. Taken together, these results suggest
that the positively charged arginine residue within the pore
of the NR1R mutant channels might directly interfere with
the desensitization gate.
In addition to the decreased rate and extent of desensiti-
zation found for the mutant receptor NR1R, we observed a
marked slowing of the 10-to-90% rise time to peak and of
current deactivation with offset of the glutamate pulse (Table
1). These results suggested that the NR1 pore mutation
might also alter the EC50 for glutamate (measured using 3-s
agonist applications). To test this possibility, we constructed
concentration-response curves comparing NR1R with wild
type. The mutant receptors showed higher sensitivity to glu-
tamate with a peak current EC50 of 1.9 M compared with
7.7 M for wild type (Fig. 1D; Table 1). Because the potency
of glutamate for activating NMDAR currents reflects the
combined processes of receptor binding and channel gating
(Colquhoun, 1998), the leftward shift in EC50 indicates that
the pore mutation alters glutamate binding affinity and/or
influences the gating process.
Distinct Two-Component Macroscopic Desensitiza-
tion of NR1Q. The idea that a mutation at Asn598 of NR1
alters channel gating was further supported by analysis of
currents mediated by the partially Ca2-permeable mutant
NR1Q. Unlike either wild type or NR1R, these currents
showed an apparently rapidly desensitizing component in
addition to the slower desensitization when recorded in the
presence of a zinc chelator (1–2 M TPEN) and saturating
glycine (Fig. 2A). The rapidly decaying component of the
current response to sustained agonist application was con-
sistent with a model for the NR1Q proposed by Schneggen-
burger and Ascher (1997), in which extracellular sodium
favors rapid transition from the main to the subconductance
state upon channel opening, leading to apparent macroscopic
desensitization (see Discussion). Interestingly, the slowly de-
caying component of macroscopic desensitization was modu-
lated by extracellular Ca2 in an unexpected manner. In the
Fig. 1. NR1R shows altered gating and agonist potency. A, currents
evoked by 1 mM glutamate with 50 M glycine (indicated by bars) for WT
(top) and NR1R (bottom) in the presence or absence of external Ca2, as
indicated. Traces shown at right were recorded in presence of 1 M
TPEN. B, currents evoked by paired pulses of glutamate recorded from
NR1R or WT illustrating time course of recovery from desensitization.
[Glu] and [Gly] same as in A. Recordings were made in absence of Ca2
and with 1 M TPEN in extracellular solution. Test pulses were applied
at intervals ranging from 1 s up to 60 s after initial (control) pulse. C, plot
of time course for recovery from desensitization, where 0% represents
current amplitude at end of desensitizing (control) pulse and 100% indi-
cates recovery to initial current amplitude for control pulse. Points indi-
cate mean  S.E.M. from n  8 and 5 different cells transfected with
NR1R and WT, respectively. All recordings were made under conditions
described in B. Data fitted to a single exponential. D, concentration-
response curve for peak glutamate-evoked current. [Gly] was 50 M.
Recordings were made in absence of Ca2 and with zinc chelator (see
Materials and Methods) in extracellular solution. Points are mean 
S.E.M. for n  4 to 7 different cells. Data fitted to the Hill equation (see
Materials and Methods).
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absence of extracellular Ca2, this component resembled de-
sensitization of wild-type receptors (P 
 0.05 by unpaired
t test), whereas in the presence of Ca2 (1.8 mM), the rate
and extent were strikingly attenuated and resembled those
of NR1R (P 
 0.05 by unpaired t test)(Fig. 2A; Table 1). The
rate of current deactivation upon glutamate withdrawal was
also influenced by extracellular Ca2—slow, as for NR1R, in
1.8 mM CaCl2 and more rapid, similar to WT, in the absence
of Ca2 (Fig. 2B; Table 1). Unlike the NR1R, however, in the
presence of external Ca2, the glutamate peak current dose-
response curve as well as the 10-to-90% rise-time to peak
current for NR1Q were similar to those measured for wild-
type receptors (Table 1). On the other hand, recovery from
slow desensitization for NR1Q occurred at a rate signifi-
cantly slower than that measured for WT (P 	 0.0001, 2-way
ANOVA), even in the absence of extracellular Ca2 (Fig. 2, C
and D; Table 1).
Pore Block by Ca2 Influences Desensitization and
Deactivation Rates for NR1Q. It is known that extracel-
lular Ca2 can bind within the pore and block ion flux
through NR1Q in a voltage-dependent manner (Premkumar
and Auerbach, 1996). Because onset of slow agonist-induced
desensitization, as well as deactivation, in the absence of
external Ca2 was similar to that of wild type NR1/NR2A but
was not statistically different from that of NR1R in the
presence of Ca2, we hypothesized that Ca2 binding to a site
within the pore of NR1Q interfered with channel gating. The
effects on gating would only occur after channel opening,
which may, in part, explain the lack of effect of external Ca2
on the NR1Q rise time and peak current EC50. This hypoth-
esis could be extended to suggest that the slowed desensiti-
zation and deactivation of NR1R currents result from the
positively charged arginine residue mimicking the effect of
Ca2 binding in the pore of NR1Q.
To test whether Ca2 entry into and/or flux through the
pore of NR1Q was necessary to reduce the rate of slow-onset
agonist-induced desensitization, we analyzed desensitization
of current responses to glutamate at a series of holding po-
tentials ranging from100 to100 mV in the presence of 1.8
mM CaCl2 and 1 to 2 M TPEN (Fig. 3A). These channels
show voltage-dependent block by external Ca2 (Fig. 3A) and
anomalous whole-cell current reversal at holding potentials
near 0 mV (not shown), as described previously (Premkumar
and Auerbach, 1996; Schneggenburger and Ascher, 1997). As
expected, the mean time constant for slow desensitization
calculated from current responses at hyperpolarized poten-
tials (100 to 40 mV) was similar to the mean time con-
stant measured previously from current responses at a hold-
ing potential of 60 mV (Fig. 3, A and B). However, the rate
of slow, agonist-induced desensitization was significantly ac-
celerated at depolarized holding potentials (40 to 100
mV), where Ca2 influx and pore block are dramatically
diminished, although it was not as fast as that observed at
60 mV for wild-type receptors or NR1Q in the absence of
external Ca2 (Fig. 3, A and B; Table 1). These results sup-
port the hypothesis that Ca2 binding to a site within the
pore of NR1Q (Premkumar and Auerbach, 1996) contributes
to the slowing of agonist-induced desensitization.
Results of Modeling Consistent with Effect of Pore
Mutations on Channel Gating. We reasoned that the ef-
fects of the pore mutations on glutamate-evoked current de-
activation and steady-state to peak ratio, as well as that of
NR1R on the rise-time and glutamate concentration-re-
sponse curve, could all be accounted for by altered rates of
channel gating without any changes in ligand unbinding
rate. Because the kinetic scheme for gating of NR1Q was
complicated by asymmetric gating under bi-ionic (external
Na and internal K) conditions, which was previously mod-
eled by Schneggenburger and Ascher (1997), we tested this
hypothesis only for NR1R, using a standard model to describe
NMDAR ligand binding and channel gating (Fig. 4A; see
Materials and Methods). For this model, the rates of desen-
sitization and resensitization were set to the values mea-
sured experimentally for NR1R (Table 1), and we initially set
the glutamate binding and unbinding rates to the values
used to model wild-type NR1/NR2A (Chen et al., 2001). We
then varied channel opening and closing rates from the rates
used for WT (Chen et al., 2001) until the model traces fit our
data for the shifted glutamate EC50, extent of desensitization
at the end of a 3-s pulse of 1 mM glutamate, and the slowed
10-to-90% rise time to peak and rate of current decay upon
withdrawal of glutamate. We found that a10-fold reduction
in the channel closing rate, with no change in channel open-
ing rate (Table 2), resulted in a model current response that
closely approximated the experimental data (Fig. 4, B and C):
the model current showed a rise-time of 13 ms, deactivation
TABLE 1
Biophysical properties of NR1R, NR1Q and WT receptor currents
Results from 3-s applications of 1 mM glutamate/50 M glycine with 1–2 M TPEN. n  6 to 15 different cells for all kinetic parameters; n  4–7 different cells for EC50
measurements.
NR1Ra WTb NR1Q 0 Ca2 NR1Q 1.8 mM Ca2
10–90% 13.4  0.3 6.4  0.2 6.7  0.4 6.8  0.3
Rise time (ms)
D (ms)
Df 54  6.5 (32%) 29  3 (67%)
Ds 4040  680 (100%) 1610  110 (100%) 1400  110 (68%) 5770  1580 (33%)
resens (s) 20.2  0.70 2.42  0.27 14.3  0.54 N.D.
Iss/Ipeak 0.93  0.01 0.74  0.03 0.54  0.04 0.63  0.03
off (ms)
off,f 170  17 (61%) 56  9 (89%) 89  11 (100%) 122  13 (62%)
off,s 611  42 (39%) 309  49 (11%) 539  45 (38%)
EC50 (M; peak current): 1.9  0.2 7.7  0.8 N.D. 8.1  0.5
N.D. not determined.
a Time course of glutamate-evoked response was not different for individual NR1R-expressing cells switched between external solutions containing no added extracellular
Ca2 versus 1.8 mM CaCl2, therefore these data were pooled.
b Results from experiments with no added extracellular Ca2 for WT.
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time constant of 360 ms (the weighted average time constant
from our data was 342 ms), steady-state to peak current ratio
of 95%, and EC50 of 1.75 M (see Table 1 for comparison with
experimental values).
To determine whether a change in ligand unbinding rate,
without any alteration in channel opening or closing rates,
could also reproduce our data, we reduced the unbinding rate
by 5- to 8-fold. Compared with the experimental values for
NR1R, a 5-fold rate reduction produced a similar shift in
EC50 but a deactivation rate that was markedly faster (220
ms), whereas an 8-fold reduction reproduced the deactivation
rate (350 ms) but shifted the EC50 to less than 1 M; both
manipulations resulted in a steady state-to-peak current ra-
tio of 72%, indicating markedly more extensive desensitiza-
tion than that observed experimentally. For comparison, we
also modeled WT, using the rates of desensitization and
resensitization measured experimentally in the absence of
external Ca2 or zinc; the binding/unbinding as well as chan-
nel opening/closing rates were the same as we had used
previously (Chen et al., 2001) (Fig. 4, B and C; Table 2).
Again, the rise-time (7 ms), deactivation time constant (45
ms), steady state-to-peak current ratio (63%), and EC50 (7
M) were all similar to our experimental data (see Table 1).
In all, these results are consistent with a model in which the
positively charged arginine residue near the external mouth
of the pore of NR1R interferes with both closing and desen-
sitization gating of the channel. Moreover, the leftward shift
in the glutamate concentration-response curve could be ex-
plained by these effects on channel gating, without any mod-
ification in ligand binding or unbinding rates.
Discussion
In this study, we have demonstrated that mutation of NR1
Asn598, a pore residue controlling ion permeation and open
channel block, modulates channel gating of NMDA receptors.
Furthermore, our data strongly suggest that slowing of de-
sensitization and deactivation gating for the NR1 mutants is
Fig. 2. NR1Q shows altered gating that is modulated by external Ca2. A,
current evoked by 1 mM glutamate plus 50 M glycine in presence or
absence of external Ca2 recorded from same NR1Q-transfected cell. B,
same traces shown in A but scaled to match peak amplitude, better
illustrating difference in rate of desensitization and deactivation in pres-
ence versus absence (*) of external Ca2. C, currents evoked by paired
pulses of glutamate (1 mM, plus 50 M glycine) recorded from NR1Q-
transfected cell in absence of external Ca2. Test pulses were applied at
intervals ranging from 1 s up to 60 s after initial (control) pulse. D, plot
of time course of recovery from desensitization for n  11 different
NR1Q-transfected cells, recorded in absence of external Ca2. 0% repre-
sents current amplitude at the end of the desensitizing (control) pulse,
and 100% indicates recovery to initial current amplitude for control pulse.
Data fitted to a single exponential. All recordings in A to D were made
with zinc chelator in extracellular solution (see Materials and Methods).
Fig. 3. Ca2-mediated pore block slows desensitization of NR1Q. A,
Representative current-voltage relation recorded from NR1Q-transfected
cell in presence of 1.8 mM CaCl2. Holding potential was 60 mV, with
jumps to voltages ranging from100 to100 mV in increments of 20 mV
during 3-s applications of 1 mM glutamate in presence of 50 M glycine.
Note increasing peak of outward current (relative to driving force), as
well as rate of desensitization, with depolarization to positive potentials.
B, mean desensitization time constant of glutamate-evoked currents re-
corded in presence of external 1.8 mM CaCl2 is significantly smaller for
pooled data from holding potentials of 40 to 100 mV compared with
100 to 40 mV (n  4 different cells; **, P 	 0.01), and approaches,
though is still significantly higher than (††, P 	 0.01), that measured for
currents recorded in the absence of CaCl2 at VH  60 mV (n  11
different cells). Note that mean time constant in 1.8 mM CaCl2 deter-
mined from pooled data at holding potentials ranging from 100 to 40
mV matches that measured at 60 mV (n  15 different cells; P  0.92).
Recordings were made in presence of extracellular 1 to 2 M TPEN.
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caused by the presence of a positively charged ion at the NR1
Asn598 site. In addition, we have shown a leftward shift of
the glutamate concentration-response for NR1R, consistent
with previous studies of NR1 pore mutations N598R or
A635T expressed with NR2B or NR2A, respectively (Kashi-
wagi et al., 1997; Kohda et al., 2000). Using a kinetic model,
we confirm that this effect results from an alteration in
channel gating rather than a more global change in receptor
conformation that affects ligand binding.
There is strong evidence indicating that Asn598 in NR1
contributes to controlling the narrow pore constriction in-
volved in determining selective ion permeability and block
and single channel conductance (Burnashev et al., 1992; Mori
et al., 1992; Sakurada et al., 1993; Behe et al., 1995; Woll-
muth et al., 1996); however, the influence of NR1 Asn598 on
NMDAR macroscopic desensitization or channel closing has
not been explored. On the other hand, a variety of data
indicates that residues lining the pore are involved in con-
formational changes that couple agonist binding to opening
of the channel activation gate. For example, the region in and
around amino acids within the NR1 C-terminal segment of
M3 (M3c), including the highly conserved SYTANLAAF
(Lurcher) motif, contributes to lining the channel in the wide,
external vestibule (Beck et al., 1999) and largely determines
the effect of protons on channel gating (Low et al., 2003). As
well, recent data suggest that the walls of this external
vestibule constrict in the channel’s closed state but do not
form the activation gate (Sobolevsky et al., 2002). Moreover,
the Lurcher mutation in the SYTANLAAF motif of NR1
(A635T  NR1Lc) when coexpressed with wild-type NR2A
shows marked slowing of deactivation and glutamate-in-
duced desensitization, a 10-fold leftward shift in the gluta-
mate dose-response curve, and a markedly slower channel
closing rate (by noise analysis) compared with wild-type
NR1/NR2A (Kohda et al., 2000), results that closely match
our data for NR1R.
Results of previous studies have also suggested a role for
M2 in channel gating. State-dependent accessibility of a sub-
stituted cysteine in NR1(N598C) supports a role for this site
in gating (Kuner et al., 1996). Another study also used the
cysteine accessibility method to compare modification rates
of NR1 residues in the external vestibule as well as deeper in
the pore (including N598C in M2), in the ligand-bound versus
unbound state, with or without the presence of a channel
blocking agent; from these data, the authors proposed that
the activation gate lies deep within the pore, near the level of
Asn598 (Sobolevsky et al., 2002). Consistent with this idea,
mutation of the tryptophan five residues toward the N ter-
minus from the Asn/Gln/Arg site (and closer to the internal
mouth of the channel) in M2 of both NR1 and NR2A resulted
in a change in NMDA channel open probability (Buck et al.,
2000). Our data, combined with a kinetic model, demonstrate
that mutation of NR1 Asn598 to the positively charged argi-
nine, or Ca2 bound in the pore with a glutamine substitu-
tion at this site, significantly slows onset of desensitization
as well as channel closing. It may be that the activation gate
is formed by the M2 loop in NMDARs, similar to the role of
the P loop in gating for cyclic nucleotide-gated channels (Sun
et al., 1996).
It has frequently been noted that ionotropic glutamate
receptors show significant structural homology with voltage-
gated potassium channels in the pore region (MacKinnon,
1995; Wo and Oswald, 1995; Wood et al., 1995); in both
families, the pore is formed by a re-entrant loop (M2 for
glutamate receptors and the P loop for potassium channels)
along with contributions from transmembrane segments
(M1, M3, and M4 for NMDARs and S5 and S6 for K chan-
nels). Previous studies have shown that pore mutations in
Shaker K channels can alter rates of channel closing and
C-type inactivation (Molina et al., 1998; Rasmusson et al.,
1998). Notably, the latter is thought to be mediated by direct
constriction (or “collapse”) of the pore itself, and this process
can be slowed by occupation of the pore by permeant ions
(Kiss and Korn, 1998; Molina et al., 1998; Rasmusson et al.,
1998).
Similar to the data for C-type inactivation of potassium
channels, previous studies have indicated that occupation of
the NMDAR pore by organic cations or other channel-block-
ing agents alters macroscopic gating. NMDARs composed of
NR2A and mutant NR1 in which cysteine was substituted at
Fig. 4. A kinetic model suggests changes in channel desensitization and
closing rate account for differences in macroscopic current kinetics and
agonist potency between NR1R and WT. A, state diagram used to model
NMDAR channel behavior. B, traces generated using parameters shown
in Table 2 to model current response to 3-s application of 1 mM glutamate
( 50 M glycine) for NR1R or WT NMDAR. C, concentration-response
curve for peak glutamate-evoked current (in 50 M glycine) based on
model simulation and fitted to Hill equation.
TABLE 2
Parameters used to model NMDAR current
Receptor Rb Ru Rd Rr Ro Rc
M1s1 s1 s1 s1 s1 s1
N598R 5 25 0.25 0.05 150 12
WT 5 25 0.62 0.41 150 150
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Ala634 (one residue before the Lurcher site) exhibited mark-
edly slowed deactivation after modification with methaneth-
iosulfonate ethylammonium (Jones et al., 2002). In other
experiments using a series of organic ions of different sizes
that bind to and produce rapid block of the open NMDAR
channel, it was shown that the activation/deactivation and
desensitization gates are near the external entrance of the
narrow constriction of the pore (i.e., at the level of Asn598),
because some of these agents prevented desensitization
and/or deactivation (Sobolevsky et al., 1999). Similarly, occu-
pation by adamantane derivatives of a binding site in the
external vestibule of NMDARs prevented channel closure
(Antonov and Johnson, 1996). These studies together with
our data are consistent with a model in which the presence of
a cation or blocking molecule at or near the narrow pore
constriction of NMDARs markedly slows or prevents channel
closing and/or desensitization.
An elegant study by Schneggenburger and Ascher (1997)
demonstrated that NR1Q shows gating asymmetry under
bi-ionic conditions. Specifically, in recordings of agonist-
evoked current responses in solutions with Na as the pri-
mary external monovalent cation and Cs as the internal
cation, they observed preferential cycling of channels from
closed to main conductance to subconductance and back to
closed states. If we assume that internal Cs and K act
similarly in the model proposed by these authors, then the
rapidly decaying macroscopic current we observed in re-
sponse to sustained agonist application could represent ini-
tial opening of channels to the main conductance state fol-
lowed by a shift toward preferential occupation of the
subconductance state as Na replaces K at a binding site
internal to the narrow constriction within the pore
(Schneggenburger and Ascher, 1997). Therefore, the appear-
ance of two distinct components of macroscopic desensitiza-
tion that we observed probably represents a rapid gating
shift from main to subconductance states of the channel,
followed by entry into the desensitized state.
It is interesting to note that although glycine-independent
desensitization is determined largely by extracellular struc-
tural regions in NR2 subunits (Krupp et al., 1998; Villarroel
et al., 1998), mutations of a pore residue in NR1 can modify
this process as well as deactivation gating. This result is
consistent with a model in which extracellular domains of
glutamate receptors involved in ligand binding adopt distinct
conformations in the closed, open, and desensitized states
(Sun et al., 2002), but movement of these extracellular do-
mains is transduced by connector regions to alter the confor-
mation of regions deep within the pore that gate ion flux. The
precise nature of the conformational changes associated with
gating that occur around the level of Asn598 in the pore
remains to be determined.
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